{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:37:56Z","timestamp":1775911076870,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116255","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:14:23Z","timestamp":1636373663000},"page":"116255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Trends in postmenopausal osteoporosis treatment in France during the period 2007\u20132016: A nationwide claims database analysis"],"prefix":"10.1016","volume":"154","author":[{"given":"Bernard","family":"Cortet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00eblle","family":"D\u00e9sam\u00e9ricq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Vannak","family":"Chauny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Samama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Emery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Fagnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bone.2021.116255_bb0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","article-title":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis","volume":"94","year":"1993","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.bone.2021.116255_bb0010","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/annrheumdis-2013-204320","article-title":"The global burden attributable to low bone mineral density","volume":"73","author":"Sanchez-Riera","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.bone.2021.116255_bb0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","article-title":"2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis","volume":"79","author":"Briot","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.bone.2021.116255_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X16685547","article-title":"The calcium and vitamin D controversy","volume":"9","author":"Abrahamsen","year":"2017","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"5","key":"10.1016\/j.bone.2021.116255_bb0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jbspin.2018.02.009","article-title":"2018 update of French recommendations on the management of postmenopausal osteoporosis","volume":"85","author":"Briot","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.bone.2021.116255_bb0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2021.116255_bb0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2021.116255_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrrheum.2017.218","article-title":"Osteoporosis in 2017: addressing the crisis in the treatment of osteoporosis","volume":"14","author":"Roux","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.bone.2021.116255_bb0045","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.3145","article-title":"Addressing the crisis in the treatment of osteoporosis: better paths forward","volume":"32","author":"Stoecker","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2021.116255_bb0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.bone.2021.116255_bb0055","unstructured":"Classification Commune des Actes m\u00e9dicaux (CCAM). https:\/\/www.ameli.fr\/accueil-de-la-ccam\/index.php. (Accessed 24 February 2020)."},{"issue":"5","key":"10.1016\/j.bone.2021.116255_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"2","key":"10.1016\/j.bone.2021.116255_bb0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the charlson comorbidity index with electronic health care database to predict mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.bone.2021.116255_bb0070","first-page":"377","article-title":"French law: what about a reasoned reimbursement of serum vitamin D assays?","volume":"14","author":"Souberbielle","year":"2016","journal-title":"Geriatr. Psychol. Neuropsychiatr. Vieil"},{"issue":"1","key":"10.1016\/j.bone.2021.116255_bb0075","doi-asserted-by":"crossref","first-page":"10361","DOI":"10.1038\/s41598-017-10263-8","article-title":"Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study","volume":"7","author":"Caillet","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bone.2021.116255_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00228-009-0746-0","article-title":"Prescription of anti-osteoporosis drugs during 2004\u20132007-a nationwide register study in Norway","volume":"66","author":"Devold","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.bone.2021.116255_bb0085","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/pds.3703","article-title":"Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy","volume":"23","author":"Peeters","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.bone.2021.116255_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.bone.2021.116255_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","article-title":"Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"6","author":"Strom","year":"2011","journal-title":"Arch Osteoporos"},{"issue":"2","key":"10.1016\/j.bone.2021.116255_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bone.2013.09.008","article-title":"Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002\u20132012","volume":"57","author":"Wysowski","year":"2013","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2021.116255_bb0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-016-3789-y","article-title":"Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up","volume":"28","author":"Belhassen","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116255_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bone.2017.08.031","article-title":"Secular trends of use of anti-osteoporotic treatments in Spain: a population-based cohort study including over 1.5 million people and more than 12 years of follow-up","volume":"105","author":"Martin-Merino","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116255_bb0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2016.10.013","article-title":"Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity","volume":"94","author":"van der Velde","year":"2017","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2021.116255_bb0120","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12325-019-00919-4","article-title":"Profile of women initiated on denosumab and pattern of use in a restricted postmenopausal osteoporosis indication: a French database analysis over the period 2013\u20132014","volume":"36","author":"Emery","year":"2019","journal-title":"Adv. Ther."},{"issue":"12","key":"10.1016\/j.bone.2021.116255_bb0125","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.2565","article-title":"Trends in media reports, Oral bisphosphonate prescriptions, and hip fractures 1996\u20132012: an ecological analysis","volume":"30","author":"Jha","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116255_bb0130","author":"HAS"},{"key":"10.1016\/j.bone.2021.116255_bb0135","author":"HAS"},{"key":"10.1016\/j.bone.2021.116255_bb0140","author":"HAS"},{"key":"10.1016\/j.bone.2021.116255_bb0145","author":"HAS"},{"key":"10.1016\/j.bone.2021.116255_bb0150","author":"HAS"},{"key":"10.1016\/j.bone.2021.116255_bb0155","series-title":"Transparency Committee Opinion of 16 July","author":"HAS","year":"2008"},{"key":"10.1016\/j.bone.2021.116255_bb0160","author":"HAS"},{"key":"10.1016\/j.bone.2021.116255_bb0165","author":"HAS"},{"issue":"5","key":"10.1016\/j.bone.2021.116255_bb0170","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00198-017-3953-z","article-title":"Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial","volume":"28","author":"Merle","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"11","key":"10.1016\/j.bone.2021.116255_bb0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2021.116255_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158365","article-title":"Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of patients' and practitioners' views","volume":"11","author":"Alami","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bone.2021.116255_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219681","article-title":"Osteoporosis prevention: where are the barriers to improvement in French general practitioners? A qualitative study","volume":"14","author":"Merle","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bone.2021.116255_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143842","article-title":"Low osteoporosis treatment initiation rate in women after distal forearm or proximal humerus fracture: a healthcare database nested cohort study","volume":"10","author":"Viprey","year":"2015","journal-title":"PLoS One"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822100421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822100421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:48:21Z","timestamp":1762660101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822100421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"alternative-id":["S875632822100421X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116255","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in postmenopausal osteoporosis treatment in France during the period 2007\u20132016: A nationwide claims database analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116255"}}